Clinical Trial Update: Preoperative Levosimendan in CABG Patients With Poor LV Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating preoperative levosimendan in patients undergoing coronary artery bypass grafting with poor left ventricular function; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Artery Bypass Grafting, Left Ventricular Dysfonction | Phase 3 | Status: COMPLETED